Cargando…
Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
Introduction: With the emergence of the Coronavirus Disease 2019 (COVID-19) as a global pandemic came the concern that it would adversely affect individuals with comorbid conditions. In sickle cell disease (SCD), the apprehension was largely driven by concerns that the disease causes chronic inflamm...
Autores principales: | Sewaralthahab, Sarah, Smith, Hedy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330263/ http://dx.doi.org/10.1182/blood-2020-139365 |
Ejemplares similares
-
Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020) -
Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020) -
Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic
por: Davila, Jennifer G., et al.
Publicado: (2020) -
Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020) -
Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
por: Abdelaal, Mahmoud A.Z., et al.
Publicado: (2020)